Pierre Azoulay

@pierre_azoulay

Professor, Sloan School of Management, MIT. Research Associate, National Bureau of Economic Research

Boston, Mass., USA
Vrijeme pridruživanja: lipanj 2011.

Tweetovi

Blokirali ste korisnika/cu @pierre_azoulay

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @pierre_azoulay

  1. proslijedio/la je Tweet
    6. velj

    MORT D'UNE LEGENDE - Kirk Douglas, le dernier géant d'Hollywood, est mort dans la nuit. Inoubliable Spartacus, l'acteur a également tourné avec les plus grands réalisateurs américains. En 1967, il disait son amour pour les westerns. Et dans un français parfait !

    Poništi
  2. proslijedio/la je Tweet
    5. velj

    Dédicacé à une boulangère sétoise, qui a levé les yeux au ciel quand je lui ai demandé une baguette.

    Poništi
  3. 1. velj

    Albert Camus-quoting epidemiologists are the best kind of epidemiologist!

    Poništi
  4. 31. sij

    and the prize for best paper title in 2020 goes to...

    Poništi
  5. 25. sij
    Poništi
  6. 24. sij

    My collaborators are not on twitter, and as a result they can't feel my pain.

    Poništi
  7. 23. sij

    7-minute abs comes to strategy (or maybe it's always been there?)

    Poništi
  8. 21. sij

    For french speakers, Benny Levy ז"ל's interview by is a pretty amazing retrospective on a very interesting life.

    Poništi
  9. 20. sij

    This Larry David impersonation is really on the nose

    Poništi
  10. 16. sij

    And this is why I am only half kidding when I say that we need our Lord & Savior Jeff Bezos to decide generics is the next blue horizon.

    Prikaži ovu nit
    Poništi
  11. 16. sij

    Applied/health econ types: this is really a great take on EQRx you might have missed. Only quibble is the contention that generics are already pretty cheap.

    Prikaži ovu nit
    Poništi
  12. 15. sij

    Narcissism of small differences. boiled flour either way. בגט רולז.

    Poništi
  13. 13. sij

    In a first-best world, Dr. Califf might well be correct. In a second-or third-best world, adding complexity to RCTs opens many additional avenues for sponsors to get the answers they are highly-motivated to find. Churchill's dictum applies to this setting as well.

    Poništi
  14. proslijedio/la je Tweet
    12. sij

    Here's a thing I don't like and I'm not sure what to do about. Academic papers (especially in applied fields) often have introductions that frame their results in terms of really big problems and over claim as to how much convincing progress they make on that big problem. 1/

    Prikaži ovu nit
    Poništi
  15. proslijedio/la je Tweet
    10. sij

    Recent editorial 👇 (by Kahneman & Renshon) offers a readable summary of many interesting ‘judgment and decision making’ findings pertinent to trigger-happy leaders. But imo ALSO exemplifies a key limitations of jdm-style explanations. (Thread.)

    Prikaži ovu nit
    Poništi
  16. proslijedio/la je Tweet
    9. sij

    Am aware of 4 major not-for-profit hospital system in-house venture funds that have shut their doors in the last several months. Entirely not surprising. Here's my take on why:

    Prikaži ovu nit
    Poništi
  17. 3. sij

    But ultimately it makes a plausible case but does not really convince. If I had a dime from every misunderstood genius thwarted by the dogmatic establishment... 2/

    Prikaži ovu nit
    Poništi
  18. 3. sij

    I ought to like this story a lot, since it highlights the role of cognitive and tangible barriers to entry in the scientific realm. /1

    Prikaži ovu nit
    Poništi
  19. proslijedio/la je Tweet
    2. sij

    The Google AI mammogram paper is FLAWED. Want to learn why? AND why cancer screening is the LAST thing you should pick FIRST to work on with AI? Read this This is educational, I promise

    Prikaži ovu nit
    Poništi
  20. 2. sij

    A note for economists: much of what I have learned about trial design in medicine comes from . /FIN

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·